top of page
Desk with Stethoscope

INUSpherese® Quellenverzeichnis

Quellen im Zusammenhang mit der INUSpherese® TKM-58:

​

Straube, R.; Müller, g.; Voit-Bak, K.; Tselmin, S.; Julius, U.;

Schatz, U.; Rietzsch, H.; Reichmann, H.; Chrousos, G.P.;

Schürmann, A.; Jark, L.; Ziemssen, T.; Siepmann,

T. & Bornstein, S.R. (2019).

Metabolic and non-metabolic peripheral neuropathy: Is there a place for therapeutic apheresis? Hormone and Metabolic Research,

51 (12), 779-784

​

Straube, R.; Voit-Bak, K.; Gor, A.; Steinmeier, T.; Chrousos, G.P.; Boehm, B.O.; Birkenfeld, A.L.; Barbir, M.; Balanzew,

W. & Bornstein, S.R. (2019).

Lipid profiles in Lyme borreliosis: A potential role for apheresis?

Hormone and Metabolic Research, 51 (05), 326-329.

​

Bornstein, S.R.; Voit-Bak, K.; Morawietz, H.; Bornstein, A.B.;

Balanzew, W.; Julius, U.; Rodionov, R.N.; Biener, A.M.; Wang,

J.; Schulte, K.M.; Krebs, P.; Vollmer, G. & Straube, R. (2020).

Is there a role for environmental and metabolic factors predisposing to severe COVID-19? Hormone and Metabolic Research, 52 (07), 540-546.

​

Bornstein, S.R.; Voit-Bak, K.; Rosenthal, P.; Tselmin, S.; Julius,

U.; Schatz, U.; Boehm, B.O.; Thuret, S.; Kempermann, G.;

Reichmann, H.; Chrousos, G.P.; Licino, J.; Wong, M.-L.; Schal-ly, A.V. (Nobel prize winner) & Straube, S.R. (2020).

Extracorporeal apheresis therapy for Alzheimer disease-targeting lipids, stress, and inflammation. Molecular Psychiatry, 25, 275-282.

​

Bornstein, S.R.; Voit-Bak, K.; Donate, T.; Rodionov, R.N.; Gainetdinov, R.R.; Tselmin, S.; Kanczowski, W.; Müller, G.M.; Achleitner, M.; Wangm, J.; Licino, J.; Bauer, M.; Young, A.H.; Thuret, S.; Bechmann, N. & Straube, R. (2022).

Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis? Molecular Psychiatry, 27, 34-37.

​

Yin, X.; Takov, K.; Straube, R.; Voit-Bak, K.; Graessler, J.; Julius, U.; Tselmin, S.; Rodionov, R.; Barbir, M.; Walls, M.; Theofilators, K.; Mayr, M. & Bornstein, S.R. (2022).

Precision medicine approach for cardiometabolic risk factors in therapeutic apheresis. Hormone and Metabolic Research, 54 (04), 238-249.

​

Scholkmann, F. & Tsenkova, R. (2022).

changes in water properties in human tissue after double filtration plasmapheresis. Molecules, 27 (12), 3947.

​

Scholkmann, F. & Gatti, A.M. (2022).

Particles in the eluate from double filtration plasmapheresis___A case study using field emission scanning electron microscopy/energy-dispersive X-ray spectroscopy (FE-SEM/EDX). Compounds, 2 (4), 367-377.

​

Allgemeine Quellen und Literaturhinweise:

​

Nadler SB, Hidalgo JU, Block T:

Prediction of blood volume in normal human adults. Surgery 1962;

5:224-232.

Cholesterol Treatment Trialists Collaboration (CTT).2015. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. Lancet 385

​

Dittrich-Riediger, J.; Schatz, U.; Hohenstein, B. and Julius, U. 2015

Adverse events lipoproteln apheresls and immunoadsorption at the Apheresis Centerat the University Hospital Dresden.

Atheroscler. Suppl, 1 8; 45-52. doi: 10.1016/j.atherosclerosissup. 2015.02.007

​

Caforio AL, Pankuweit sS Arbustini E et al.

Current state of knowledge on etiology, diagnosis, management, and therapy of myocarditis; a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur

Heart J 2013; 34: 2636-48; 2648a-2648d.

​

Clifford DB, De Luca A, Simpson DM et al.

Natalizumabassociated progressive multifocal leukoencephalopathy in patients with multiple sclerosis; lessons from 28 cases. Lancet Neuro 2010; 4

​

Gold R. Dianose und Therapie der Multiplen Sklerose

In: Diener & Weimar Hrsg, Leitlinien für Diagnostik und Therapien in der Neurologie der Deutschen Gesellschaft für Neurologie, Stuttgart, New York: Thieme, September 2012. URL: https:// www.dgn.org/leitlinien/2333-II-31-2012-diagnose-und-therrapie-dermultiplens-klerose (Zugriff am 30.08. 2017).

​

Hohenstein B., Passauer J.; Ziemssen T. and Julius U.

Immunoadsorption with regenerating systems in neurological disorders - A single center experience Atheroscler Suppl 2015; 119-123.

​

Dogan Onugoren MD, Golombeck K, Bien C et al.

Immunoadsorption therapy in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 2016; 3 (2);e 207 DOI 10.1212/NXI.0000000000000207

​

Cortese I, Chaudhry V, So Y et al. Evidence-based guideline update:

plasmapheresis in neurologic disorders:

report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 2011; 76; 294-300.

​

Sommer c et al. (2018)

Therapie akuter und chronischer immunvermittelter Neuropathien und Neuritiden, S2eLeitlinie, In: Deutsche Gesellschaft für Neurologie (Hrsg) Leitlinien für Diagnostik und Therpaie in der Neurologie.

​

Berlit P, et al.,

Neurologische Manifestationen bei COVID-19, S2k-Leitlinie, 2022, In: Deutsche Gesellschaft für Neurologie (Hrsg.), Leitlinien für Diagnostik und Therpapie in der Neurologie. Online: www.dgn.org/leitlinien

​

Islam MS, Azim F, Saju H, Zargaran A, Shirzad M, Kamal M, Fatema K, Rehman S, Azad MAM, Ebrahimi-Barough S. J chem Neuroanat. 2021 Sep;

Pesticides and Parkinson's disease: Current and future perspective.

​

Ascherio A, Schwarzschild MA. Lancet Neurol. 2016 Nov;

The epidemiology of Parkinson's disease: risk factors and prevention

​

Alvarado-Esquivel C, Méndez-Hernández EM, Salas-Pacheco JM, Ruano-Calderón LÁ, Hernández-Tinoco J, Arias-Carrión O, Sánchez-Anguiano LF, Castellanos-Juárez FX, Sandoval-Carrillo AA, Liesenfeld O, Ramos-Nevárez A. BMJ Open. 2017 Feb

toxoplasma gondii, exposure and Parkinson's disease: a case of control study

​

Fallahi S, Rostami A, Birjandi M, Zebardast N, Kheirandish F, Spotin A. Acta Trop. 2017.

Parkinson's disease and Toxoplasma gondii infection: Sero-molecular assess the possible link among patients.

​

Senejani AG, Maghsoudiou J, El-Zohiry D, Gaur G, Wawrzeniak K, Caravaglia C, Khatri VA, MacDonald A, Sapi E. J Alzheimers Dis. 2022.

Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer's Disease Brain Tissues

​

Haahr R, Tetens MM, Dessau RB, Krogfelt KA, Bodilsen J, Andersen NS, Moller JK, Roed C, Christiansen CB, Ellermann-Eriksen S, Bangsborg JM, Hansen K, Benfield TL, Andersen CO, Obel N, Lebech AM, Omland LH. Clin Infect Dis. 2020 Sep.

Risk of Neurological Disorders in Patiens With European Lyme Neuroborreliosis: A Nationwide, Population-Based Cohort Study

​

Wormser GP, Marques A, Pavia CS, Schwartz I, Feder HM, Pachner AR. Clin Infect Dis. 2022 Aug.

Lack of Convincing Evidence That Borrelia burgdorferi Infection Causes Either Alzheimer Disease or Lewy Body Dementia

​

MacDonald AG. Med Hypotheses. 2006;

Spirochetal cyst forms in neurodegenerative disorders, hiding in plain sight

​

Parthasarathy G, Pattison MB, Midkiff CC. J Neuroinflammation. 2023 Jan

The FGF/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: likely intersectionality with other neurological conditions

​

Seward RJ, Drouin EE, Steere AC, Costello CE. Moi Cell Proteomics, 2011 Mar;

Peptides presented by HLA-DR molecules in sysnovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis

​

Steere AC, Dwyer E, Winchester R. N Engl J Med. 1990 Jul.

Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles

​

Weyand CM, Jendro M, Goronzy JJ. Autoimmunity. 1991;

SolubleHLA-DR molecules in patients with HLA class II versus class I associated disorders

​

Flegr J. Parasit Vectors. 2021 Sep 28;

Toxoplasmosis is a risk factor for acquiring SARS-CoV-2 infection and a

​

Gustaw K, Beltowska K, Dlugosz E. Ann Agric Environ Med. 2005;

Co-existance of toxoplasmosis and neuroborreliosis - a case report

​

Shutikova AL, Leonova GN, Popov AF, Shchelkanov MY. Klin Lab Diagn. 2021.

Clinical and diagnostic manifestations of tickborne mixed infection in combination with COVID-19 Nov.

​

Szewczyk-Dabrowska A, Budziar W, Harhala M, Baniecki K, Pikies A, Jedruchniewicz N, Kazmierczak Z, Gembara K, Klimek T, Witkiewicz W, Nahorecki A, Barczyk K, Klak M, Grata-Borkowska U, Dabrowska K. Sci Rep. 2022 Sep 24

Correlation between COVID-19 severity and previous exposure of patients to Borrelia spp

​

bottom of page